Reliable prediction of survival in advanced-stage hepatocellular carcinoma treated with sorafenib: comparing 1D and 3D quantitative tumor response criteria on MRI-Reference-Cited by-同舟云学术

Reliable prediction of survival in advanced-stage hepatocellular carcinoma treated with sorafenib: comparing 1D and 3D quantitative tumor response criteria on MRI

Published:2020-10-30 Issue:5 Volume:31 Page:2737-2746
ISSN:0938-7994
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Doemel Luzie A.,Chapiro Julius,Laage Gaupp Fabian,Savic Lynn Jeanette,Kucukkaya Ahmet S.,Petukhova Alexandra,Tefera Jonathan,Zeevi Tal,Lin MingDe,Schlachter Todd,Jaffe Ariel,Strazzabosco Mario,Patel Timil,Stein Stacey M.

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00330-020-07381-9.pdf

Reference35 articles.

1. Dimitroulis D, Damaskos C, Valsami S et al (2017) From diagnosis to treatment of hepatocellular carcinoma: an epidemic problem for both developed and developing world. World J Gastroenterol 23(29):5282–5294

2. Forner A, Reig ME, Rodriguez de Lope C, Bruix J (2010) Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis 30(01):061–074

3. Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359(4):378–390

4. Cheng A-L, Kang Y-K, Chen Z et al (2009) Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 10(1):25–34

5. Bruix J, Qin S, Merle P et al (2017) Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 389(10064):56–66

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor response assessment in hepatocellular carcinoma treated with immunotherapy: imaging biomarkers for clinical decision-making;European Radiology;2024-07-20

2. Using three-dimensional model-based tumour volume change to predict the symptom improvement in patients with renal cell cancer;3 Biotech;2024-05

3. Appropriate use of morphological imaging for assessing treatment response and disease progression of neuroendocrine tumors;Best Practice & Research Clinical Endocrinology & Metabolism;2023-09

4. Comparison of quantitative volumetric analysis and linear measurement for predicting the survival of Barcelona Clinic Liver Cancer 0- and A stage hepatocellular carcinoma after radiofrequency ablation;Diagnostic and Interventional Radiology;2023-05-01

5. Molecular and functional imaging in cancer-targeted therapy: current applications and future directions;Signal Transduction and Targeted Therapy;2023-02-27